LoginRegister

    Suven Life Sciences secures Product Patents in China, Eurasia

    Written by Ruby Khatun Khatun   |  
    Suven Life Sciences secures Product Patents in China, Eurasia

    Mumbai: Pharma Major, Suven Life Sciences Ltd announced the grant of one product patent from China and one product patent from Eurasia corresponding to the New Chemical Entity for the treatment of disorders associated with Neurodegenerative diseases and patents.


    The patents are valid through 2034.


    The granted claims of the patents include the class of selective 5-HT4 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia and sleep disorders like Narcolepsy etc, Suven life said in a filing with BSE.


    ''We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential global'' says Venkat Jasti, CEO of Suven.

    Alzheimer's diseaseAttention deficient hyperactivity disorderchinacognitive impairmentEurasiaHuntington’s diseasenarcolepsyneurodegenerative diseasesnew chemical entityParkinsonpatentsproduct patentsschizophreniasecuresSuven LifeSuven Life SciencesVenkat Jasti
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X